1. Introduction {#sec1}
===============

Both type 1 and type 2 diabetes can be attributed to a failure of insulin-producing β-cells. For the development of regenerative therapies, the reconstitution of β-cell mass under metabolically challenging conditions has therefore attracted great research interest. Initial lineage tracing studies concluded that self-replication accounts for nearly all of the turnover and regeneration of adult β-cells [@bib1], [@bib2]. Other investigators reported non-β-cell precursors for adult β-cells in specific contexts, such as pancreatic duct ligation [@bib3], [@bib4], [@bib5], pregnancy [@bib6], extreme β-cell ablation [@bib7], [@bib8], or induced differentiation [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15]. The concept of interconversion of different pancreatic cell types is emerging, but its quantitative contribution to the cell-autonomous process, i.e. without any genetic or pharmacological manipulations, of β-cells turnover upon metabolic challenges remains largely unknown. Furthermore, most of these studies used the tamoxifen-inducible CreER/loxP system to label specific pools of cells in a temporally controlled manner. However, recent observations have cast doubt on the ability of temporal control of gene expression/elimination with tamoxifen [@bib16]. In adipocytes, the residual tamoxifen enables nuclear translocation of the CreER recombinase beyond two months of a washout period, along with significant metabolic side effects due to the pharmacological nature of tamoxifen as an estrogen receptor antagonist [@bib17]. It is therefore essential to gain a better understanding of the actions of tamoxifen in the context of β-cell lineage tracing studies, compare it to other systems, and re-visit the data interpretation if necessary. As an alternative, the doxycycline-inducible system has proven to generate reliable lineage tracing results in adipose tissue, with fewer side effects and better temporal control on Cre recombinase activity [@bib17], [@bib18].

As a common strategy for regenerative studies, β-cell ablation can be induced in adult rodents through a variety of methods, including pancreatectomy, pancreatic duct ligation, and administration of streptozotocin, alloxan, targeted delivery of diphtheria toxin, or targeted mutations in critical genes [@bib19]. These approaches have disadvantages such as unspecific ablation [@bib20], poor control over the extent of the ablation, unspecific toxicity, limited regenerative capacity post ablation [@bib21], or irreversibly impaired functionality or viability of surviving β-cells. In contrast, the PANIC-ATTAC ("pancreatic islet β-cell apoptosis through targeted activation of caspase 8") transgenic mouse has been characterized as a model of inducible, titratable, acute β-cell apoptosis [@bib22], [@bib23]. Administration of a chemical dimerizer, which is nontoxic and has a short half-life of around 5 h in mice, activates the intracellular apoptosis signaling in β-cells. In adult mice, the dimerizer-induced β-cell death peaks by 2 weeks post treatment, without any detectable inflammation (F4/80 or CD3 immunostaining, data not shown) or other side effects. More importantly, a moderate ablation, as indicated by a peak fed blood glucose level of 250--600 mg/dL accompanied by 50--75% β-cell loss, allows for autonomous recovery of β-cell mass and blood glucose by 10 weeks post treatment.

Here, we utilized the PANIC-ATTAC model to trace the regenerated β-cells with a tamoxifen-inducible labeling system. After a short washout of 1 week, the nuclear Cre was sustained by the residual tamoxifen activity and labeled most of the insulin^+^ cells during the chase phase. In contrast, a much more extensive washout period of 4 months revealed ∼20% β-cells with a non-β-cell origin. This was further confirmed independently with a doxycycline-inducible lineage tracing system. Such a significant contribution from non-β-cells was also evident after multiparity or high-fat diet-induced obesity. Labeling other pancreatic cells with the doxycycline system identified the glucagon-producing α-cell as a predominant source of β-cell trans-differentiation in the cases of post-apoptosis regeneration and multiparity. In contrast, in diet-induced obesity, β-cell conversion contributed to about one fourth of the expanded α-cell pool, explaining the disorganized distribution of α-cells post high-fat diet. In fact, *de novo* and/or trans-differentiation were active mechanisms to replenish α-cells. We failed to detect any acinar-to-β-cell trans-differentiation. Ectopic expression of Nkx6.1, a key transcription factor for β-cell differentiation [@bib24] and identity [@bib25], promotes α-cell trans-differentiation and systemic insulin production. Here, we provide comprehensive and highly quantitative measurements of the autonomous contributions from multiple pancreatic cell types to the adult β-cell pool upon different metabolic challenges. Our results suggest that adult β-cells preferentially originate from cells with relatively small developmental distance and high pre-existing abundance, and the relative contribution can be changed by metabolic insults or pharmacological interventions. We demonstrate the general usefulness of our lineage tracing system for the comprehensive and quantitative analysis of pancreatic cell fate and for the development of regenerative therapies.

2. Materials and methods {#sec2}
========================

2.1. Mice {#sec2.1}
---------

The transgenic mouse strains *MIP-CreER*^*T2*^, *MIP-rtT*A, *PPG-rtTA* [@bib26], and *TRE-Nkx6.1* were generated and recently characterized by our laboratory. The transgene constructs were generated by subcloning the coding DNA sequence (CDS) into a plasmid containing the promoter: *MIP-CreER*^*T2*^, the 1983-bp *CreER*^*T2*^ CDS following a 8.3-kb mouse insulin 1 promoter; MIP-rtTA, the 747-bp *rtTA.M2* CDS following a 8.3-kb mouse insulin 1 promoter; PPG-rtTA, the 747-bp *rtTA.M2* CDS following a 1.7-kb mouse preproglucagon promoter; TRE-Nkx6.1, the 1098-bp golden hamster *Nkx6.1* CDS following a 0.3-kb TRE-tight promoter. The PANIC-ATTAC transgenic mouse was generated by our laboratory as previously described [@bib22]. The mouse strains *TRE-Cre* (\#006234), *RIP-rtTA* (\#008250), *Rosa26-LacZ* (*Rosa26-loxP-STOP-loxP-LacZ*, \#003474), *Rosa26-Tomato* (*Rosa26-loxP-STOP-loxP-tdTomato Ai9*, \#007909), and *Ptf1a-rtTA* (\#018070) were purchased from the Jackson Laboratory. All mice were bred in the C57BL/6 genetic background. Mice were fed on regular (LabDiet \#5058), high-fat (60%, Research \#D12492), or doxycycline chow diet (600 mg/kg, Bio-Serv \#S4107). Mice were maintained in 12-h dark/light cycles, with *ad libitum* access to diet and water. All protocols for mouse use and euthanasia were reviewed and approved by the Institutional Animal Care and Use Committee of the University of Texas Southwestern Medical Center.

2.2. Genotyping PCR {#sec2.2}
-------------------

Approximately 3 mm of mouse tail tip was incubated in 80 μL 50 mM NaOH at 95 °C for 1.5 h. 8 μL 1 M Tris--HCl (pH 8.0) was added for neutralization. After vortexing and a short spin down, 0.5--1 μL of supernatant was used as PCR template. Primer sequences for genotyping PCR are listed in [Table S1](#appsec2){ref-type="sec"}. The PCR program was: 95 °C for 5 min, followed by 35 cycles of 95 °C for 15 s, 62 °C for 30 s, and 72 °C for 30 s, and ended with 72 °C for 3 min.

2.3. Tamoxifen administration {#sec2.3}
-----------------------------

A 25-mg tamoxifen citrate pellet with a release time of 21 days (Innovative Research \#E-351) was implanted subcutaneously, and the mice were housed individually during the release period.

2.4. Dimerizer administration {#sec2.4}
-----------------------------

Mice were subjected to one intraperitoneal injection of the dimerizer AP20187 (Clontech \#635059) at the dose of 0.3--0.5 μg/g body weight/day. The dimerizer stock solution was stored at −80 °C, and freshly diluted in 2% Tween-20 with 10% polyethylene glycol 400 before injection.

2.5. Multiparity {#sec2.5}
----------------

Adult female mice were mated to be pregnant at least three times and sacrificed for pancreas paraffin sections during the last pregnancy, at around 15.5 days post-coitus.

2.6. β-gal staining {#sec2.6}
-------------------

Mice were subjected to isoflurane anesthesia and cardiac perfusion of 0.2% glutaraldehyde in PBS (10--15 mL per mouse). Tissues were immediately dissected, transferred to 20-mL scintillation vials with 0.2% glutaraldehyde in PBS, and minced into 1--3 mm wide slices. Tissue slices were washed with rinse buffer (0.1 M sodium phosphate, 2 mM MgCl~2~, 0.01% sodium deoxycholate, and 0.02% NP-40, pH 7.3) three times for 30 min and incubated with X-gal staining buffer (1 g/L X-galactoside, 5 mM K~3~\[Fe(CN)~6~\], and 5 mM K~4~\[Fe(CN)~6~\] in rinse buffer) in the dark, at room temperature, with shaking at 100 rpm, for 24 h. Tissues slices were then fixed in 10% formalin overnight and briefly rinsed three times with 50% ethanol. In the University of Texas Southwestern Medical Center Molecular Pathology Core, tissue slices were embedded in paraffin blocks, and the sections were counterstained with Nuclear Fast Red. Bright field images were acquired on a Nikon Coolscope digital microscope or an Olympus FSX100 all-in-one microscope.

2.7. Immunohistochemistry {#sec2.7}
-------------------------

Mouse tissues were collected and processed for paraffin sections as previously described [@bib23]. Primary antibodies and dilution for immunostaining or immunofluorescence were: β-galactosidase (1:50, Abcam \#ab9361), insulin (1:500, Dako \#A0564), Cre (1:100, Millipore \# 69050-3), RFP for tdTomato (rabbit polyclonal, 1:100, Abcam \#ab34771), RFP for tdTomato (mouse monoclonal, 1:250, ThermoFisher \#MA5-15257), glucagon (1:500, Invitrogen \#18-0064), Nkx6.1 (1:50, Santa Cruz Biotechnology \#sc-15027), and Amylase (1:800, Cell Signaling \#3796). Images were acquired on a Nikon Coolscope digital microscope, a Zeiss Axio Observer Z1 inverted microscope, or an Olympus FSX100 all-in-one microscope.

2.8. Assay of metabolites {#sec2.8}
-------------------------

Tail blood was collected with a heparinized Microhematocrit capillary tube (Fisher Scientific \#22-362-566) and prepared for plasma. Glucose was measured with a glucose meter or colorimetric assays with PGO enzymes (Sigma \#P7119) plus o-dianisidine (Sigma \#F5803). Insulin was measured with an ELISA kit (Crystal Chem \#90080).

2.9. RT-qPCR on pancreatic islets {#sec2.9}
---------------------------------

Mouse pancreatic islets of Langerhans were isolated as previously described [@bib23]. Total RNA was extracted with an RNeasy Mini kit (Qiagen \#74106). cDNA was synthesized with a SuperScript II reverse transcriptase (Invitrogen \# 18064-014) plus the RNaseOUT recombinant ribonuclease inhibitor (Invitrogen \# 10777-019). Quantitative real-time PCR (qPCR) was performed with the Power SYBR Green PCR master mix (Applied Biosystems \# 4368708) on a 7900HT Fast Real-Time PCR System (Applied Biosystems \# 4329001). Primer sequences for qPCR are listed in [Table S2](#appsec2){ref-type="sec"}.

2.10. Glucose tolerance test {#sec2.10}
----------------------------

Mice were fasted for 4--6 h and subjected to an oral gavage of dextrose (2 mg/g body weight). Tail blood was collected at 0, 15, 60, and 120 min, prepared for plasma, and assayed for glucose and insulin.

2.11. Data analysis {#sec2.11}
-------------------

Immunofluorescence-stained cell numbers, as well as islet areas, were quantitated with ImageJ. Cell percentages in individual islets were presented as bubble charts, with the bubble size proportional to the denominator cell number. For an individual mouse, every cell population was summed from all the examined islets respectively, and calculated for percentages. The area under curve (AUC) in tolerance tests was calculated for individual mouse by the trapezoidal method. Two-tailed student\'s t-test was applied for all paired and unpaired comparisons. Statistical significance was accepted at *P* \< 0.05.

3. Results {#sec3}
==========

3.1. Only extended washout periods for tamoxifen unmask the non-β-cell origins of autonomous β-cell regeneration {#sec3.1}
----------------------------------------------------------------------------------------------------------------

We employed a tamoxifen-inducible system to label the pre-existing β-cells in adult mice. A 25-mg tamoxifen pellet was subcutaneously implanted to the \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*\] mouse, and released tamoxifen for a 21-day period. Only in the presence of tamoxifen, the CreER^T2^ protein translocated into the nucleus, removed the floxed stop codon in the *Rosa26-LacZ* locus, and activated the expression of β-galactosidase (β-gal) permanently ([Figure 1](#fig1){ref-type="fig"}A). After the 3-week release and 1-week washout of tamoxifen, the insulin^+^ cells were nearly 100% β-gal^+^, as displayed by both β-gal staining ([Figure 1](#fig1){ref-type="fig"}B) and immunofluorescence ([Figure S1A](#appsec2){ref-type="sec"}). At this point, the labeled mice carrying the *PANIC-ATTAC* transgene were subjected to dimerizer-induced β-cell apoptosis, followed by two months of autonomous regeneration. Consistent with our previous report [@bib22], the β-cell ablation was evident by hyperglycemia two weeks after dimerizer administration, and a significant decrease in blood glucose 10 weeks post dimerizer as the result of the recovery of β-cell mass ([Figure S1B](#appsec2){ref-type="sec"}). In the regenerated islets, there was no apparent evidence of β-cells originating from any precursors other than β-cells ([Figure 1](#fig1){ref-type="fig"}B).

Tamoxifen has a prolonged activity in CreER^T2^ nuclear translocation, which may confound the results of lineage tracing experiments [@bib16], [@bib17]. To establish a time point when the β-cells are functionally free of tamoxifen activity, we examined the subcellular location of the CreER^T2^ protein by immunofluorescence ([Figure 1](#fig1){ref-type="fig"}C). Importantly, the nuclear CreER^T2^ signal was sustained beyond the 1-week washout period and became undetectable after 4 months of washout. At this point, the labeled islet cells remained mostly β-gal^+^ ([Figure 1](#fig1){ref-type="fig"}D).

To quantitatively trace the origins of autonomously regenerated β-cells, we employed another reporter, tdTomato, and generated the \[*MIP-CreER*^*T2*^; *Rosa26-Tomato*; *PANIC-ATTAC*\] mouse model ([Figures 1](#fig1){ref-type="fig"}E, F and [S1C](#appsec2){ref-type="sec"}). After a 4-month washout of tamoxifen, 98.1 ± 0.8% insulin^+^ cells remained as Tomato^+^. When mice were subjected to dimerizer-induced ablation and autonomous regeneration of β-cells only after the 4 month washout, they displayed 21 ± 6% of Tomato^−^ cells in the insulin^+^ cell population after recovery. The significant increase (*P* = 0.04) in Tomato^−^insulin^+^ cells suggested an important contribution of non-β-cells to adult β-cell regeneration. This is also independently supported by the β-gal^−^ cells in the islets of \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*; *PANIC-ATTAC*\] mice ([Figure 1](#fig1){ref-type="fig"}D).

3.2. *Tet-On* lineage tracing quantitates the non-β-cell contribution to adult β-cell turnover {#sec3.2}
----------------------------------------------------------------------------------------------

To improve the temporal control in lineage tracing experiments, we employed the doxycycline-inducible gene expression system ("*Tet-On*"). We created a MIP-rtTA transgenic mouse strain, which showed no activity in tissues ([Figure S2](#appsec2){ref-type="sec"}) other than pancreatic β-cells [@bib26] and crossed the mice to generate the \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] and \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice. The rtTA protein is expressed exclusively in insulin^+^ β-cells and activates the local expression of Cre only in the presence of doxycycline. The nuclear localization sequence-fused Cre protein translocates into the nucleus and irreversibly activates the expression of reporter genes (*LacZ* or *tdTomato*) in the cell and its progeny ([Figure 2](#fig2){ref-type="fig"}A). After 1 week of doxycycline diet, the Cre protein was detected in the nuclei of nearly all insulin^+^ cells, and could no longer be detected in the nucleus within 1 week after doxycycline withdrawal ([Figure 2](#fig2){ref-type="fig"}B). In agreement with the qualitative β-gal reporter expression ([Figure 2](#fig2){ref-type="fig"}C), after dimerizer-induced β-cell ablation and autonomous regeneration (with the ATTAC challenge) ([Figure S3A](#appsec2){ref-type="sec"}), the Tomato^−^insulin^+^/insulin^+^ cell ratio increased from 2.8 ± 0.6% to 18 ± 3% (*P* = 0.002) ([Figure 2](#fig2){ref-type="fig"}D and E). Hence, a significant contribution of non-β-cells to the autonomous regeneration of adult β-cells is supported by the Tet-On system, consistent with the observations in the tamoxifen system after prolonged washout period ([Figure 1](#fig1){ref-type="fig"}E and F).

We utilized the Tet-On system to trace the lineages of adult β-cells upon other metabolic challenges ([Figure 2](#fig2){ref-type="fig"}C, D and E). We allowed female mice to undergo at least 3 pregnancies, which implements cycles of β-cell hyperplasia and apoptosis at low frequency [@bib27]. Under these conditions, about 11 ± 4% of insulin^+^ cells were Tomato^−^, i.e. multiparous female mice display slightly more than one in ten β-cells that originate from non-β-cells. In male mice, after 15 weeks of high-fat diet-induced obesity ([Figure S3B](#appsec2){ref-type="sec"}), we detected a 9 ± 1% contribution (*P* = 0.02) to the β-cell population from non-β-cells. Despite the heterogeneity among individual islets, the distribution of their cell ratios was consistent with the cell population ratio seen amongst different mice ([Figure S3C](#appsec2){ref-type="sec"}). These results suggest that upon a variety of challenges, a contribution of non-β-cells to the adult β-cell pool is routinely seen to a significant extent, and may reach as much as 20% in systems with a high reliance on β-cell apoptosis, such as the PANIC-ATTAC mouse.

Importantly, we also examined the *[de]{.ul}*differentiation and/or *[trans]{.ul}*-differentiation of adult β-cells under the different conditions by quantitating the Tomato^+^insulin^−^/Tomato^+^ cell ratio ([Figures 2](#fig2){ref-type="fig"}F and [S3D](#appsec2){ref-type="sec"}). This process was significant only after the ATTAC challenge (3.3 ± 0.9% versus 0.12 ± 0.09% in controls, *P* = 0.02), and no significant change was observed in the cases of multiparity or diet-induced obesity. We further investigated whether these former β-cells trans-differentiate into glucagon-producing α-cells in the islets ([Figure 3](#fig3){ref-type="fig"}A). The Tomato^+^glucagon^+^ cells accounted for \<3% of the Tomato-tagged cells ([Figures 3](#fig3){ref-type="fig"}B and [S4A](#appsec2){ref-type="sec"}), consistent with the Tomato^+^insulin^−^ population ([Figure 2](#fig2){ref-type="fig"}F). However, they composed 25 ± 3% of the α-cell pool after the challenge with diet-induced obesity, but not upon exposure to the ATTAC treatment or multiparity ([Figures 3](#fig3){ref-type="fig"}C and [S4B](#appsec2){ref-type="sec"}). This finding suggests the chronic β-cell hyperplasia induces active β-to-α conversion and provides an explanation for the disorganized α-cell distribution in obese mouse islets.

3.3. Glucagon-producing α-cells are the main sources of newly converted adult β-cells {#sec3.3}
-------------------------------------------------------------------------------------

The newly differentiated β-cells can originate from *de novo* differentiation of precursor cells and/or trans-differentiation of other mature cell types in the pancreas. Previous studies have shown the progressive α-to-β cell conversion upon extreme β-cell loss accompanied by insulin treatment in adult or aged mice [@bib7], [@bib8]. By generating the \[*PPG-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mouse model, we measured the contribution of glucagon-producing α-cells to the autonomous β-cell regeneration after moderate β-cell ablation by 50--75% (data not shown). Expression of the rtTA protein is directed by the promoter for the preproglucagon gene, and the tdTomato reporter is specifically expressed in α-cells after doxycycline treatment ([Figure 4](#fig4){ref-type="fig"}A). Washout of doxycycline for 1 week completely abolished Cre protein expression in α-cells ([Figure S5](#appsec2){ref-type="sec"}). In \[*TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice lacking rtTA, \<2.0% insulin^+^ cells were reporter-tagged after the ATTAC challenge, reflecting only negligible activity caused by the leaky expression of the *TRE-Cre* gene ([Figures 4](#fig4){ref-type="fig"}B, C, E and [S6](#appsec2){ref-type="sec"}).

We allowed the ATTAC-challenged \[*PPG-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice more than 2 months of regeneration (week 10). The Tomato^+^insulin^+^/insulin^+^ cell ratio was increased from 4 ± 1% to 20 ± 4% (*P* = 0.003), indicating a very significant conversion of α-to-β trans-differentiation ([Figures 4](#fig4){ref-type="fig"}D, F and [S7A](#appsec2){ref-type="sec"}). At an earlier time point (week 5) of the regeneration time course ([Figure S7B](#appsec2){ref-type="sec"}), there were fewer Tomato^+^ cells within the insulin^+^ cell population (8 ± 4%, *P* = 0.06 versus the no challenge control) ([Figure 4](#fig4){ref-type="fig"}D and F), supporting a mechanism with progressive α-to-β conversion. In multiparous females, the Tomato^+^insulin^+^/insulin^+^ cell ratio was also prominently increased to 13.0 ± 0.9% (*P* = 0.001). However, the obese males ([Figure S7C](#appsec2){ref-type="sec"}) did not show a significant α-to-β conversion (6 ± 2%, *P* = 0.4), consistent with the active reverse β-to-α conversion under high-fat diet ([Figures 3](#fig3){ref-type="fig"}C and [S4B](#appsec2){ref-type="sec"}).

Assuming the reporter expression did not affect cell fates, an increase in the Tomato^−^glucagon^+^/glucagon^+^ cell ratio would suggest a replenishment of α-cells through *de novo* or trans-differentiation. Such trends were indeed observed in all the challenged groups, most significantly in the multiparous females ([Figure S8](#appsec2){ref-type="sec"}). In the case of diet-induced obesity, β-cell trans-differentiation contributed to one fourth of the α-cell pool, which represents a major source of the newly differentiated α-cells ([Figures 3](#fig3){ref-type="fig"}C and [S4B](#appsec2){ref-type="sec"}). All of the post-challenge Tomato^+^insulin^+^/insulin^+^ cell ratios were significantly higher than those observed in the \[*TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice ([Figure 4](#fig4){ref-type="fig"}E), indicating that these labels are not artifacts from a leaky *TRE-Cre* expression.

Taken together, these results demonstrate quantitatively the inter-conversion plasticity of adult α-cells and β-cells. Upon the challenges of induced (ATTAC) or repeated (multiparity) β-cell-apoptosis followed by regeneration, α-cells make an important contribution to adult β-cell pool and are the major sources of the newly differentiated β-cells. In contrast, diet-induced obesity, insulin resistance and the consequent chronic β-cell hyperplasia do not stimulate the α-to-β conversion. Instead, a minor portion (\<3%) of the enriched β-cell pool trans-differentiates into a significant portion (∼25%) of the α-cells.

3.4. Pancreatic acinar cells do not contribute to adult β-cell regeneration {#sec3.4}
---------------------------------------------------------------------------

We also assessed the contribution of the exocrine pancreatic acinar cells towards regeneration of β-cell mass by generating the \[*Ptf1a-rtTA*; *TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] mice ([Figure 5](#fig5){ref-type="fig"}A). The specific expression of Cre in acinar cells responded promptly to the administration and withdrawal of doxycycline ([Figure 5](#fig5){ref-type="fig"}B). With complete labeling of the surrounding acinar cells, few β-gal^+^ islet cells were observed under normal or challenged conditions ([Figures 5](#fig5){ref-type="fig"}C and [S9](#appsec2){ref-type="sec"}), suggesting the contribution of autonomous acinar-to-β trans-differentiation is marginal under the conditions examined.

Combining our results with previous studies [@bib3], [@bib4], [@bib5], [@bib7], [@bib8], [@bib9], [@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib19], [@bib28], [@bib29], we proposed a "kinetic" model of adult β-cell generation ([Figure 5](#fig5){ref-type="fig"}D), generally applicable to the conversion of cell identities *in vivo*. Analogous to the stochastic models of chemical reactions [@bib30], the kinetics of the conversion from certain pancreatic cell types to β-cells depends on (1) the "energy barrier", i.e. the difficulty for the conversion to happen. This step positively correlates with the developmental distance between the precursor and the progeny. Self-replication has the lowest barrier and the highest potential. Cells closely related to the β-cells, such as α-cells and δ-cells [@bib31], may readily undergo de-differentiation and re-differentiation, or even direct interconversion by regulating key transcription factors. Exocrine acinar cells share a distant progenitor with β-cells, and the conversion happens extremely slowly, if at all. An endogenous progenitor cell may lie somewhere in-between these cell types. The conversion barriers are likely to be lower at the embryonic and postnatal stages than in adulthood, conferring more plasticity to differentiated cell types. Exogenous induction or metabolic challenges may also catalyze some subtypes of conversions. (2) The conversion from certain pancreatic cell types to β-cells also depends on the population size of the precursor cells. Like the concentration of chemical reactants, the more abundant a precursor cell type is, the more it contributes to the progeny population. Hence, β-cell self-replication [@bib23], [@bib32], [@bib33] plays a predominant role unless the original population of mature β-cells is depleted to an extreme extent (\>99%) [@bib7], [@bib8] or with irreversibly impaired viability [@bib19]. In the setting of moderate (70--85% in PAINC-ATTAC, data not shown) or repeated (multiparity) β-cell apoptosis, α-cells stand out from the other non-β endocrine cells due to their relative abundance [@bib34]. Their conversion can be induced by genetic manipulation of transcription factors [@bib12], [@bib13], [@bib15] or a tumor suppressor [@bib14]. The contributions from δ-cells [@bib8], Ngn3^+^ endogenous progenitor cells [@bib4], and ductal cells [@bib3], [@bib13] are context-dependent or hardly detectable, because of their limited number and/or more distantly-related genetic programs. Considering the very large population size, acinar cells could be a potent target for induced conversion [@bib10], [@bib11], but, in the models used here, there is no detectable contribution to the β-cell pool under any circumstances. When the β-cell population is chronically enriched, e.g. during diet-induced obesity, the process drives the reverse conversion into α-cells.

3.5. Nkx6.1 promotes α-to-β trans-differentiation {#sec3.5}
-------------------------------------------------

A validation of this model can be to decrease the barriers of cell conversion to examine whether such steps can promote trans-differentiation. Since the α-cell is the major precursor of adult β-cell regeneration post apoptosis in our PANIC-ATTAC mouse, we investigated whether this process can be promoted by overexpression of a key transcription factor for β-cell differentiation, such as Nkx6.1. This is a transcription factor that plays a key role in maintaining identity and function of the β-cell [@bib24], [@bib25], [@bib35]. We generated a *TRE-Nkx6.1* transgenic mouse that enabled us to take advantage of doxycycline-inducible overexpression in adults. When crossed with the *RIP-rtTA* transgenic mouse, the exogenous Nkx6.1 is overexpressed and functional in pancreatic islets, as demonstrated by moderately increased expression of insulin and cell cycle regulators such as Cdk2 ([Figure S10A](#appsec2){ref-type="sec"}). After doxycycline treatment on the \[*Ptf1a-rtTA*; *TRE-Nkx6.1*\] mice, ectopic expression of Nkx6.1 emerged in a majority of pancreatic acinar cells, and showed a conspicuous nuclear localization ([Figure S10B](#appsec2){ref-type="sec"}). We also detected nuclear Nkx6.1 in glucagon^+^ islet cells of the doxycycline-treated \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice, though at a lower proportion ([Figure S10C](#appsec2){ref-type="sec"}).

In the \[*Ptf1a-rtTA*; *TRE-Nkx6.1*\] mice, we did not detect any amylase^+^ cells expressing insulin ([Figure S11](#appsec2){ref-type="sec"}). In contrast, in the \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice, ectopic expression of Nkx6.1 in α-cells significantly increased the glucagon^+^insulin^+^ cell proportion in glucagon^+^ cells (*P* = 0.005) ([Figures 6](#fig6){ref-type="fig"}A and [S12](#appsec2){ref-type="sec"}), suggesting active α-to-β conversion. To investigate whether this conversion can be further enhanced after β-cell apoptosis, we generated the \[*PPG-rtTA*; *TRE-Nkx6.1*; *PANIC-ATTAC*\] mice and subjected them to dimerizer administration. These hyperglycemic mice also showed a significant increase in the glucagon^+^insulin^+^/glucagon^+^ cell ratio compared to the \[*PPG-rtTA*; *PANIC-ATTAC*\] controls (*P* = 0.01), and the fold change was similar to the unchallenged group ([Figures 6](#fig6){ref-type="fig"}A and [S12](#appsec2){ref-type="sec"}). Interestingly, the glucagon^+^ cell proportion in the pancreatic islets significantly increased in the groups post β-cell ablation ([Figure S13](#appsec2){ref-type="sec"}). Hence there were more glucagon^+^insulin^+^ cells per unit area of the islets ([Figure S14](#appsec2){ref-type="sec"}).

To evaluate if the ectopic Nkx6.1-promoted α-to-β cell conversion can improve insulin production, we performed oral glucose tolerance test. In both the unchallenged ([Figure 6](#fig6){ref-type="fig"}B, C, D) and ATTAC-challenged ([Figure 6](#fig6){ref-type="fig"}E, F, G) groups, the *in vivo* glucose-stimulated insulin secretion was significantly increased in the Nkx-6.1-overexpressing mice, but not in the control cohort. Although this increase was not sufficient to improve glucose tolerance ([Figure S15](#appsec2){ref-type="sec"}), it provides evidence, in principle, that the trans-differentiated β-cells are functional.

Collectively, our results suggest that ectopic expression of Nkx6.1 can promote β-cell conversion in α-cells but not in exocrine acinar cells. This forced α-to-β conversion improves insulin production and release in both normal and diabetic mice.

4. Discussion {#sec4}
=============

The tamoxifen-inducible Cre/loxP system was almost exclusively used in the previous lineage tracing studies for the insulin-producing β-cells. While these experiments were very elegant and state-of-the-art at the time, they may have provided somewhat misleading results. In experiments labeling pre-existing β-cells, no evidence of a non-β-cell contribution to adult β-cell regeneration was observed when the washout period between the tamoxifen pulse and the turnover chase was short, such as less than 1 week [@bib1], [@bib2]. However, such evidence was more easily found when the washout period was extended to months [@bib6]. Powers and colleagues reported tamoxifen-driven nuclear translocation of Cre recombinase lasting beyond 1 month in β-cells [@bib16]. We recently demonstrated a prolonged presence of residual tamoxifen in adipocyte lineage tracing experiments, leading to artifacts [@bib17]. In previous studies [@bib1], [@bib2], [@bib6], tamoxifen treatment via intraperitoneal injections labeled \<50% β-cells. To quantitate the minor contribution from non-β-cells, we optimized the tamoxifen administration protocol to achieve nearly 100% labeling of pre-existing β-cells, as the doxycycline system does. Here we demonstrate how the short and long washout periods for tamoxifen lead to different results and opposite conclusions in the context of β-cell lineage tracing. The contribution from non-β-cells to the post-apoptosis regeneration of β-cells is evident if the chase starts after the confirmed clearance of nuclear Cre (4 months), but it is completely concealed if the washout period is merely 1 week. This difference is not attributable to the non-β-cell differentiation during the extended washout period, since the ratio of reporter-positive β-cells remains close to 100%. In the latter case, the residual tamoxifen activity and the presence of nuclear Cre continue to label the insulin^+^ cells, including those originating from the non-β-cell, and create false-positive results for this lineage tracing setting. Taken together, our findings call for caution in the usage of tamoxifen and data interpretation in lineage tracing experiments and suggest the measurement of nuclear Cre recombinase as an indicator of tamoxifen activity.

We further established doxycycline-inducible systems to label β-cells, glucagon-producing α-cells or exocrine acinar cells with high specificity and high efficiency. This system allows us to quantitatively assess their contributions to the adult β-cell pool under various pathophysiological conditions, such as post-apoptosis autonomous regeneration in adult mice. Consistent with the tamoxifen system with proper washout time, the Tet-On system highlights in the regenerated islets ∼20% insulin^+^ cells not originating from pre-existing β-cells. Such contributions are also evident in mice after multiple pregnancies, i.e. cycles of β-cell hyperplasia and apoptosis [@bib27], as well as diet-induced obesity, although to a lesser extent. Labeling the glucagon-producing α-cell in the pulse stage reveals it to be a major source of the newly differentiated β-cells in the cases of ATTAC regeneration and multiparity. Of note, our results do not exclude minor contributions from other differentiated cell types [@bib3], [@bib8] or endogenous progenitors [@bib4]. Conversely, we observe no β-cell conversion from the exocrine acinar cells in adult mice, in line with previous reports [@bib28], [@bib29]. However, this can be seen at a significant degree by cytokine treatment [@bib11] or transcriptional manipulation [@bib10]. In fact, our results support a "kinetic" model for β-cell replenishment as an analogy to the kinetic theory of chemical reactions [@bib30]. The stochastic models of microscopic reactant particles/precursor cells suggest their reaction/conversion kinetics depends on both their abundance and the energy/developmental barriers. The more developmentally related cells are more readily used: first, self-replication; and second, trans-differentiation from related cell types, such as the endocrine α-cells or δ-cells [@bib8]. The less related cell types, e.g. the exocrine acinar cells, make minimal contributions.

We provide the first, precise characterization of the contribution of α-cells to the cell-autonomous processes of adult β-cell turnover, which is supported with direct lineage tracing evidence. As the two most abundant cell types in the endocrine pancreatic islets, adult α-cells and β-cells have the plasticity to compensate for each other under specific metabolic conditions. The progressive α-to-β conversion is a predominant mechanism of the limited β-cell regeneration in adult mice subjected to diphtheria toxin-induced, extreme β-cell loss (\>99%) and kept alive by insulin treatment [@bib7], [@bib8]. In this setting, the initial β-cell population was ablated too much to make a significant contribution. Similarly, β-cells with irreversible loss of TIF-IA fail to survive or proliferate and solicit non-β-cells as the primary source of regeneration [@bib19]. Artificial induction of α-to-β conversion can be achieved by overexpression of Pax4 [@bib12], [@bib13] or Pdx1 [@bib15] in progenitor cells or α-cells, as well as endocrine tumorigenesis [@bib14]. Other studies support the α-to-β mechanism with observations of glucagon^+^insulin^+^ bihormonal cells [@bib5], [@bib19]. In the PANIC-ATTAC model with more moderate β-cell ablation followed by autonomous regeneration without any exogenous support or interference, the remnant β-cell population renders their self-replication as the primary source of regeneration, while α-cell trans-differentiation emerged as a significant, but secondary mechanism. Interestingly, α-to-β conversion is also relevant in the context of multiparity. The postnatal β-cell apoptosis may trigger the conversion, which subsequently contributes to the acute β-cell hyperplasia during the next pregnancy. The signal transduction may involve the decrease in vicinal insulin concentration or other metabolites, which awaits future investigation. Contrarily, in diet-induced obesity, the chronic β-cell hyperplasia favors the reverse β-to-α conversion.

On the other hand, we provide proof of principle that ectopic expression of Nkx6.1 in α-cells can promote α-to-β conversion and improve insulin production in adult mice. In contrast, no trans-differentiation was observed in the exocrine acinar cells with forced expression of Nkx6.1. Compared to the high frequency of Nkx6.1^+^ but absence of insulin^+^ acinar cells, the relatively rare Nkx6.1^+^glucagon^+^ and insulin^+^glucagon^+^ cells on the pancreas section may suggest a rapid conversion of identity and/or an α-cell-specific suppression on Nkx6.1. The underlying mechanisms, such as whether this conversion is reversible, and whether it triggers new α-cell generation, remain to be studied. Alternatively, an overexpression cocktail of Nkx6.1 and other β-cell transcription factors, such as Pdx1 [@bib15], MafA, and NeuroD, may further potentiate the α-to-β conversion. Interestingly, in β-cell-ablated mice, the ectopic Nkx6.1 drives the trans-differentiation at a similar percentage to α-cells as in the euglycemic mice. However, the bihormonal cell population increases along with the increased α-cell population. It further highlights the clinical potential for α-to-β conversion, considering the much higher proportion of α-cells in human islets [@bib36].

The Tet-On system for lineage tracing of pancreatic cells has multiple advantages. First, based on the similar labeling efficiency (∼100%), prompt (\<1 week) and complete washout of doxycycline-driven Cre expression grants much better temporal control than the tamoxifen system. Second, administration of the water-soluble doxycycline produces fewer side effects than that of the oil-based tamoxifen, which triggers an acute lipoatrophy [@bib17] and chronic lesions [@bib16]. These side effects can be especially confounding in mouse models with impaired β-cells or other metabolic disorders. Third, specific cell types can be labeled by adopting an appropriate promoter-driven *rtTA* transgene. We have successfully labeled the β-cell, α-cell, and pancreatic acinar cell. Other cell types such as pancreatic ductal cells, endocrine δ-cells, PP cells, ε-cells, and endogenous progenitor cells can be targeted and studied for their potential to emerge as β-cells. In fact, this system can also be used to validate new *rtTA* transgenic strains. Fourth, it can be adapted to other reporters, e.g. mTmG and HPAP, and facilitate the quantitation of different cell populations. Last but not least, this system can be readily subjected to various physiological/pathological conditions, or induction of differentiation, and studied for the developmental mechanisms.

5. Conclusions {#sec5}
==============

In summary, we establish an efficient and adaptable lineage tracing system for pancreatic cells, quantitatively identify the sources of adult β-cells under multiple metabolic conditions, and propose a kinetic model of cell conversion. Our data also reconcile the discrepant findings generated by the tamoxifen-inducible system.
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The following are the Supplementary data related to this article:Figure S1Tamoxifen-induced lineage tracing of adult β-cell regeneration. (**A**) Immunofluorescence of β-galactosidase (β-gal) on pancreas sections from \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*\] mice without tamoxifen treatment (left), and after 3-week tamoxifen release followed by 1-week washout (right). Top panels: β-gal (red) signal only. Bottom panels: β-gal merged with insulin (green). Scale bar: 100 μm. (**B**) Fed blood glucose of \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*; *PANIC-ATTAC*\] and \[*MIP-CreER*^*T2*^; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice 2 and 10 weeks after dimerizer administration. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**C**) \[*MIP-CreER*^*T2*^; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 3-week tamoxifen release and 4-month washout. Before and after the ATTAC challenge, pancreas sections were subjected to immunofluorescence of tdTomato and insulin. The examined islets of individual mice are plotted as circles, which area represents the number of insulin^+^ cells in the islet, and the center position marks the percentage of Tomato^−^ cells in the insulin^+^ cell population.Figure S2Characterization of the *MIP-rtTA* transgenic mouse. \[*MIP-rtTA*; *TRE-LacZ*\] and *TRE-LacZ* control mice were fed on doxycycline diet for 10 days. The indicated tissues were subjected to X-gal staining (blue), paraffin sectioning, and nuclear fast red (NFR, red) counterstaining. Scale bars: 400 μm (top panels) or 50 μm (bottom panels).Figure S3Doxycycline-induced lineage tracing of adult β-cells. \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] and \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, dimerizer-induced β-cell apoptosis and autonomous regeneration (ATTAC), multiple pregnancies, or high-fat diet-induced obesity. (**A**) Fed blood glucose of ATTAC-challenged mice 2 and 10 weeks after dimerizer administration. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**B**) Fed body weight of male mice before and after 15 weeks of high-fat diet regimen. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**C** and **D**) Mouse pancreas sections were subjected to immunofluorescence of tdTomato and insulin. The examined islets of individual mice are plotted as circles, which area represents the total number of insulin^+^ (**C**) or Tomato^+^ (**D**) cells in the islet, and the center position marks the percentage of Tomato^−^insulin^+^ (green) cells (**C**) or Tomato^+^insulin^−^ (red) cells (**D**) in the corresponding population.Figure S4Adult α-cells converted from β-cells. \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or high-fat diet-induced obesity. Pancreas sections were subjected to immunofluorescence of tdTomato and glucagon. The examined islets of individual mice are plotted as circles, which area represents the total number of Tomato^+^ (**A**) or glucagon^+^ (**B**) cells in the islet, and the center position marks the percentage of Tomato^+^glucagon^+^ (yellow) cells in the corresponding population.Figure S5Rapid washout of doxycycline-induced Cre expression in pancreatic α-cells. Immunofluorescence of Cre recombinase on pancreas sections from \[*PPG-rtTA*; *TRE-Cre*\] mice after 1-week doxycycline diet (left) or after 2-week doxycycline diet and 1-week washout (right). Top panels: Cre (red) signal only. Bottom panels: Cre merged with insulin (green) and DAPI (blue) signals. Arrowheads: the nuclear Cre signal co-localized with DAPI (purple). Scale bar: 100 μm.Figure S6Background labeling from *TRE-Cre* leaky expression. \[*TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 2-week doxycycline diet, 1-week washout, and subsequent challenges of ATTAC, multiparity, or diet-induced obesity. (**A**) Fed blood glucose of ATTAC-challenged mice 2 and 10 weeks after dimerizer administration. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**B**) Fed body weight of male mice before and after 15 weeks of high-fat diet regimen. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**C**) Mouse pancreas sections were subjected to immunofluorescence of tdTomato and insulin. The examined islets of individual mice are plotted as circles, which area represents the number of insulin^+^ cells in the islet, and the center position marks the percentage of Tomato^+^ cells in the insulin^+^ cell population.Figure S7The contribution of α-cells to adult β-cells. \[*PPG-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 2-week doxycycline diet followed by 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or diet-induced obesity. The ATTAC-challenged mice were examined at 10 or 5 weeks after dimerizer administration. (**A** and **B**) Fed blood glucose of ATTAC-challenged mice 2 and 10 weeks (**A**) or 2 and 5 weeks (**B**) after dimerizer administration. Dots connected by line represent individual mice. \**P* \< 0.05, \*\**P* \< 0.01 by paired *t*-test. (**C**) Fed body weight of male mice before and after 15 weeks of high-fat diet regimen. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**D**) Mouse pancreas sections were subjected to immunofluorescence of tdTomato and insulin. The examined islets of individual mice are plotted as circles, which area represents the number of insulin^+^ cells in the islet, and the center position marks the percentage of Tomato^+^ cells in the insulin^+^ cell population.Figure S8Newly generated α-cells. \[*PPG-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 2-week doxycycline diet followed by 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or diet-induced obesity. The ATTAC-challenged mice were examined at 10 or 5 weeks after dimerizer administration. (**A**) Pancreas sections were subjected to immunofluorescence of tdTomato (red) and glucagon (green). Top panels: Tomato signal only. Bottom panels: Tomato merged with glucagon and DAPI (blue). Scale bar: 100 μm. (**B**) Every mouse was counted for the total numbers of Tomato^−^glucagon^+^ cells and glucagon^+^ cells, and calculated for percentage. Data are presented as mean ± SEM. Dots: individual mice. \**P* \< 0.05 versus the no challenge control, by unpaired *t*-test. (**C**) The examined islets of individual mice are plotted as circles, which area represents the number of glucagon^+^ cells in the islet, and the center position marks the percentage of Tomato^−^ cells in the glucagon^+^ cell population.Figure S9Metabolic parameters of challenged mice after acinal cell-labeling. \[*Ptf1a-rtTA*; *TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] mice were subjected to 1-week of doxycycline diet and 1-week washout. (**A**) Fed blood glucose of ATTAC-challenged mice 2 and 10 weeks after dimerizer administration. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test. (**B**) Fed body weight of male mice before and after 15 weeks of high-fat diet regimen. Dots connected by line represent individual mice. \*\**P* \< 0.01 by paired *t*-test.Figure S10Ectopic expression of functional Nkx6.1. (**A**) *RIP-rtTA* and \[*RIP-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet for 3 days, and subjected to pancreatic islet isolation. The isolated islets were subjected to RNA extraction and RT-qPCR analysis on gene expression. Primers were designed to detect both the endogenous and exogenous Nkx6.1 (*total Nkx6.1*), the exogenous golden hamster Nkx6.1 only (*ghNkx6.1*), and other indicated genes. Data are presented as mean ± SEM in logarithmic scale. n = 3 mice per genotype. \**P* \< 0.05, \*\**P* \< 0.01 by unpaired *t*-test. (**B**) *Ptf1a-rtTA* and \[*Ptf1a-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet for 10 days. Pancreas sections were immunostained for Nkx6.1 (brown) and counterstained with hematoxylin (blue). Bottom panels (scale bar: 50 μm) show the boxed area in the top panels (scale bar: 400 μm). Dash line: islet area. Arrowheads: nuclear Nkx6.1 in exocrine acinar cells. (**C**) *PPG-rtTA* and \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet for 2 days. Pancreas sections were subjected to immunofluorescence of Nkx6.1 (red) merged with glucagon (green) and DAPI (blue). Arrowheads: nuclear Nkx6.1 (purple) in glucagon^+^ (green) cells.Figure S11Undetectable insulin expression in Nkx6.1-expressing acinar cells. \[*Ptf1a-rtTA*; *TRE-Nkx6.1*\] mice and *Ptf1a-rtTA* controls were fed on doxycycline diet for 10 days. Pancreas sections were subjected to immunofluorescence of amylase (red) and insulin (green). Top panels: amylase signal only. Bottom panels: amylase merged with glucagon and DAPI (blue). Scale bar: 100 μm.Figure S12Quantitation of insulin-expressing α-cells in \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice. *PPG-rtTA* and \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet. \[*PPG-rtTA*; *PANIC-ATTAC*\] and \[*PPG-rtTA*; *TRE-Nkx6.1*; *PANIC-ATTAC*\] mice were subjected to dimerizer-induced β-cell apoptosis (ATTAC) followed by doxycycline diet regimen. Pancreas sections were subjected to immunofluorescence of glucagon and insulin. (**A**) Every mouse was counted for the total numbers of glucagon^+^insulin^+^ cells and glucagon^+^ cells, and calculated for percentage. Data are presented as mean ± SEM. Dots: individual mice. \**P* \< 0.05 versus the *TRE-Nkx6.1* negative control, by unpaired *t*-test. (**B**) The examined islets of individual mice are plotted as circles, which area represents the number of glucagon^+^ cells in the islet, and the center position marks the percentage of insulin^+^ cells in the glucagon^+^ cell population.Figure S13Quantitation of α-cells in \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice. *PPG-rtTA* and \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet for 1 week. \[*PPG-rtTA*; *PANIC-ATTAC*\] and \[*PPG-rtTA*; *TRE-Nkx6.1*; *PANIC-ATTAC*\] mice were subjected to dimerizer-induced β-cell apoptosis (ATTAC) and, 2 weeks later, doxycycline diet regimen for another week. Pancreas sections were subjected to immunofluorescence of glucagon and insulin. (**A**) Every mouse was counted for the total number of glucagon^+^ cells, and normalized against the total islet area. Data are presented as mean ± SEM. Dots: individual mice. \#\#*P* \< 0.01 versus the no challenge control, by unpaired *t*-test. (**B**) The examined islets of individual mice are plotted as circles, which area represents the islet size, and the center position marks the density of glucagon^+^ cells in the islet.Figure S14Quantitation of bi-hormonal cells in \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice. *PPG-rtTA* and \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet for 1 week. \[*PPG-rtTA*; *PANIC-ATTAC*\] and \[*PPG-rtTA*; *TRE-Nkx6.1*; *PANIC-ATTAC*\] mice were subjected to dimerizer-induced β-cell apoptosis (ATTAC) and, 2 weeks later, doxycycline diet regimen for another week. Pancreas sections were subjected to immunofluorescence of glucagon and insulin. (**A**) Every mouse was counted for the total number of glucagon^+^insulin^+^ cells, and normalized against the total islet area. Data are presented as mean ± SEM. Dots: individual mice. \*\**P* \< 0.01 versus the *TRE-Nkx6.1* negative control, \#*P* \< 0.05 versus the no challenge control, by unpaired *t*-test. (**B**) The examined islets of individual mice are plotted as circles, which area represents the islet size, and the center position marks the density of glucagon^+^insulin^+^ cells in the islet.Figure S15Glucose tolerance in \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice. Before and after doxycycline diet, \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice and the *PPG-rtTA* controls (**A**--**C**), or ATTAC-challenged \[*PPG-rtTA*; *TRE-Nkx6.1*; *PANIC-ATTAC*\] mice and the \[*PPG-rtTA*; *PANIC-ATTAC*\] controls (**D**--**F**), were subjected to oral glucose tolerance test and assayed for blood glucose. n ≥ 7 mice per condition. (**A** and **D**) Blood glucose concentrations at the indicated time points are presented as mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 versus the *TRE-Nkx6.1* negative controls, by unpaired *t*-test. (**B**, **C**, **E** and **F**) Areas under curve of individual mice before and after doxycycline are presented as dots and connected by line.
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![Tamoxifen-pulsed linage tracing of regenerated β-cells. (**A**) Tamoxifen-inducible labeling of β-cells in mice. The transgene *MIP-CreER*^*T2*^ expresses exclusively in the insulin-producing β-cells a Cre recombinase fused with ER^T2^, a ligand-binding domain of mutated estrogen receptor. Tamoxifen binds the CreER^T2^ protein and transports it into the nucleus, where it excises the loxP-flanked stop codon in the *Rosa26* knock-in locus and activates the reporter gene (*LacZ* or *tdTomato*) expression irreversibly and heritably. (**B**) X-gal staining (blue) of pancreas from \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*\] mice without tamoxifen treatment (left), after 3-week release from the subcutaneously implanted tamoxifen pellet and 1-week washout (middle), and \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*; *PANIC-ATTAC*\] mice after 3-week tamoxifen release, 1-week washout, dimerizer-induced β-cell apoptosis, and 2-month autonomous regeneration (the ATTAC challenge, right). Paraffin sections of the X-gal stained pancreas were counterstained with nuclear fast red (NFR, red). Scale bar: 50 μm. (**C**) Immunofluorescence of Cre recombinase on pancreas sections from *MIP-CreER*^*T2*^ mice without tamoxifen treatment, after 1-week tamoxifen release, after 3-week tamoxifen release and 1-week washout, and after 3-week tamoxifen release and 4-month washout, as indicated. Top panels: Cre (red) signal only. Bottom panels: Cre merged with insulin (green) and DAPI (blue) signals. Arrowheads: the nuclear Cre signal co-localized with DAPI (purple). Scale bar: 100 μm. (**D**--**F**) \[*MIP-CreER*^*T2*^; *Rosa26-LacZ*; *PANIC-ATTAC*\] and \[*MIP-CreER*^*T2*^; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 3-week tamoxifen release and 4-month washout. Before (left) or after (right) the ATTAC challenge, (**D**) X-gal (blue) staining of pancreas from the *Rosa26-LacZ* mice. Scale bars: 50 μm. (**E**) Immunofluorescence of tdTomato (red) and insulin (green) on pancreas sections from the *Rosa26-Tomato* mice. Top panels: Tomato signal only. Bottom panels: Tomato merged with insulin and DAPI (blue). Arrowheads: Tomato^−^insulin^+^ cells (green). Scale bar: 100 μm. (**F**) In each mouse from (**E**) the total numbers of Tomato^−^insulin^+^ cells and insulin^+^ cells were counted and calculated for percentage. Data are presented as mean ± SEM. Dots: individual mice. \**P* \< 0.05 by unpaired *t*-test.](gr1){#fig1}

![Doxycycline-inducible linage tracing of adult β-cells. (**A**) Doxycycline-inducible labeling of β-cells in mice. The transgene *MIP-rtTA* expresses a reverse tetracycline transactivator (rtTA) specifically in β-cells. In the presence of doxycycline, rtTA activates the transcription of the *TRE-Cre* transgene. The Cre recombinase in turn activates the β-cell-specific expression of the reporter gene (*LacZ* or *tdTomato*) in an irreversible and heritable manner. (**B**) Immunofluorescence of Cre recombinase on pancreas sections from \[*MIP-rtTA*; *TRE-Cre*\] mice after 1-week doxycycline diet, before (left) and after (right) 1-week washout. Top panels: Cre (red) signal only. Bottom panels: Cre merged with insulin (green) and DAPI (blue) signals. Arrowheads: the nuclear Cre signal co-localized with DAPI (purple). Scale bar: 100 μm. (**C**--**E**) \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] and \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiple pregnancies, or high-fat diet-induced obesity. (**C**) X-gal (blue) staining of pancreas from the *Rosa26-LacZ* mice. Scale bars: 50 μm ("no challenge" and "ATTAC") or 100 μm ("multiparity" and "high-fat diet"). (**D**) Immunofluorescence of tdTomato (red) and insulin (green) on pancreas sections from the *Rosa26-Tomato* mice. Top panels: Tomato signal only. Bottom panels: Tomato merged with insulin and DAPI (blue). Arrowheads: Tomato^−^insulin^+^ cells (green). Scale bar: 100 μm. (**E** and **F**) In each mouse from (**D**), the total numbers of Tomato^−^insulin^+^ cells and insulin^+^ cells (**E**), or the total numbers of Tomato^+^insulin^−^ cells and Tomato^+^ cells (**F**), were counted and calculated for percentage. Data are presented as mean ± SEM. Dots: individual mice. \**P* \< 0.05, \*\**P* \< 0.01 versus the no challenge control, by unpaired *t*-test.](gr2){#fig2}

![Active β-to-α conversion in diet-induced obese mice. \[*MIP-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiple pregnancies, or high-fat diet-induced obesity. (**A**) Immunofluorescence of tdTomato (red) and glucagon (green) on pancreas sections. Top panels: glucagon signal only. Bottom panels: Tomato merged with glucagon and DAPI (blue). Arrowheads: Tomato^+^glucagon^+^ cells (yellow). Insets: representative Tomato^+^glucagon^+^ cells in the boxed area. Scale bar: 100 μm. (**B** and **C**) In each mouse from (**A**), the total numbers of Tomato^+^glucagon^+^ cells were counted, and calculated for percentage in the population of Tomato^+^ (**B**) or glucagon^+^ (**C**) cells. Data are presented as mean ± SEM. Dots: individual mice. \*\**P* \< 0.01 versus the no challenge control, by unpaired *t*-test.](gr3){#fig3}

![The contribution of α-cells to the adult β-cell turnover. (**A**) Doxycycline-inducible labeling of glucagon-producing α-cells in mice. The transgene *PPG-rtTA* expresses the rtTA protein specifically in α-cells. In the presence of doxycycline, rtTA activates the expression of Cre, and consequently the reporter tdTomato irreversibly and heritably in α-cells. (**B** and **C**) \[*TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] and \[*TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] control mice were subjected to mice were subjected to 2-week doxycycline diet, 1-week washout, and subsequent challenges of ATTAC, multiparity, or diet-induced obesity. (**B**) X-gal (blue) staining of pancreas from the *Rosa26-LacZ* mice. Scale bars: 50 μm. (**C**) Immunofluorescence of tdTomato (red) and insulin (green) on pancreas sections from the *Rosa26-Tomato* mice. Top panels: Tomato signal only. Bottom panels: Tomato merged with insulin and DAPI (blue). Scale bar: 100 μm. (**D**) \[*PPG-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] mice were subjected to 2-week doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or diet-induced obesity. The ATTAC-challenged mice were examined at 10 or 5 weeks after dimerizer administration as indicated. Pancreas sections were subjected to immunofluorescence of tdTomato (red) and insulin (green). Top panels: Tomato signal only. Bottom panels: Tomato merged with insulin and DAPI (blue). Arrowheads: Tomato^+^insulin^+^ cells (yellow). Scale bar: 100 μm. (**E** and **F**) Every \[*TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] (**E**) and \[*PPG-rtTA*; *TRE-Cre*; *Rosa26-Tomato*; *PANIC-ATTAC*\] (**F**) mouse examined in (**C**) and (**D**), respectively, was counted for the total numbers of Tomato^+^insulin^+^ cells and insulin^+^ cells, and calculated for percentage. Data are presented as mean ± SEM. Dots: individual mice. \*\**P* \< 0.01 versus the no challenge control, by unpaired *t*-test.](gr4){#fig4}

![No detectable contribution of exocrine acinar cells to adult β-cell turnover. (**A**) Doxycycline-inducible labeling of pancreatic acinar cells in mice. The transgene *Ptf1a-rtTA* expresses a reverse tetracycline transactivator (rtTA) specifically in acinar cells. In the presence of doxycycline, rtTA activates the transcription of the *TRE-Cre* transgene. The Cre recombinase in turn activates the expression of the *LacZ* reporter in acinar cells irreversibly and heritably. (**B**) Immunofluorescence of Cre recombinase in pancreas from \[*Ptf1a-rtTA*; *TRE-Cre*\] mice after 1-week doxycycline diet, before (left) and after (right) 1-week washout. Top panels: Cre (red) signal only. Bottom panels: Cre merged with insulin (green) and DAPI (blue) signals. The nuclear Cre signal is co-localized with DAPI (purple). Scale bar: 100 μm. (**C**) \[*Ptf1a-rtTA*; *TRE-Cre*; *Rosa26-LacZ*; *PANIC-ATTAC*\] mice were subjected to 1-week of doxycycline diet and 1-week washout. Subsequently, mice were subjected to no challenge, an ATTAC challenge, multiparity, or diet-induced obesity. Pancreas were subjected to X-gal (blue) staining and processed for paraffin sections. Scale bars: 50 μm ("no challenge" and "ATTAC") or 100 μm ("multiparity" and "high-fat diet"). (**D**) A kinetic model of adult β-cell generation. The contribution of certain cell type to the β-cell pool depends on its number and "differentiation barrier". Self-replication of pre-existing β-cells is the most readily approach, and is the predominant source unless β-cells are extremely ablated [@bib7]. As the second abundant endocrine cell type in the islet, α-cell can contribute significantly upon β-cell loss, presumably by switching on/off some key transcription factors. Conversely, β-to-α conversion is active during chronic β-cell hyperplasia, e.g. in diet-induced obesity. Differentiation from endocrine δ-cells [@bib8], endogenous progenitors [@bib4], or ductal cells [@bib3] were observed before adulthood or with certain induction, due to the limited number or developmental distance. As the most abundant pancreatic cell type, the exocrine acinar cell has a great potential in artificially induced β-trans-differentiation [@bib10], [@bib11], but its autonomous conversion is rare in adulthood [@bib28], [@bib29].](gr5){#fig5}

![Nkx6.1 ectopic expression in α-cells promotes insulin production. *PPG-rtTA* and \[*PPG-rtTA*; *TRE-Nkx6.1*\] mice were fed on doxycycline diet for 1 week. \[*PPG-rtTA*; *PANIC-ATTAC*\] and \[*PPG-rtTA*; *TRE-Nkx6.1*; *PANIC-ATTAC*\] mice were subjected to dimerizer-induced β-cell apoptosis (ATTAC) and, 2 weeks later, doxycycline diet regimen for another week. (**A**) Immunofluorescence of insulin (green) and glucagon (red) on pancreas sections. Top panels: insulin signal only. Bottom panels: insulin merged with glucagon and DAPI (blue). Arrowheads: glucagon^+^insulin^+^ cells (yellow). Insets: representative glucagon^+^insulin^+^ cells in the boxed area. Scale bar: 100 μm. (**B**--**G**) Plasma insulin during oral glucose tolerance test on the unchallenged (**B**--**D**) and ATTAC-challenged (**E**--**G**) mice before and after doxycycline diet. n ≥ 7 mice per condition. (**B** and **E**) Plasma insulin concentrations at the indicated time points are presented as mean ± SEM. \**P* \< 0.05, \*\**P* \< 0.01 for \[*PPG-rtTA*; *TRE-Nkx6.1*\] vs *PPG-rtTA* mice, by unpaired *t*-test. (**C**, **D**, **F** and **G**) Areas under curve of individual mice before and after doxycycline are presented as dots and connected by line. \**P* \< 0.05, \*\**P* \< 0.01 by paired *t*-test.](gr6){#fig6}

[^1]: Present address: Center for Metabolic and Degenerative Diseases, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
